ARS Pharmaceuticals (SPRY) EBIT (2020 - 2026)
ARS Pharmaceuticals' EBIT was -$61.47 million in Q2 2026, compared with -$47.61 million a year earlier.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) EBIT (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, ARS Pharmaceuticals' EBIT was -$216.27 million through Jun 30, 2026; for FY2025, it was -$179.45 million.
- In earlier years, EBIT was -$3.08 million in FY2024, -$67.52 million in FY2023, -$35.52 million in FY2022 and -$19.45 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBIT in data going back to Q1 2020.
- Per Business Quant data, SPRY's EBIT in the three quarters before Q2 2026 was -$60.15 million (Q1 2026), -$41.47 million (Q4 2025) and -$53.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | ARS Pharmaceuticals | 428.58 Mn | 284.78 Mn | 20.81 Mn | -61.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -61.47 Mn |
| Mar 31, 2026 | -60.15 Mn |
| Dec 31, 2025 | -41.47 Mn |
| Sep 30, 2025 | -53.19 Mn |
| Jun 30, 2025 | -47.61 Mn |
| Mar 31, 2025 | -37.18 Mn |
| Dec 31, 2024 | 47.20 Mn |
| Sep 30, 2024 | -21.75 Mn |
| Jun 30, 2024 | -15.34 Mn |
| Mar 31, 2024 | -13.19 Mn |
| Dec 31, 2023 | -10.23 Mn |
| Sep 30, 2023 | -17.98 Mn |
| Jun 30, 2023 | -20.60 Mn |
| Mar 31, 2023 | -18.71 Mn |
| Dec 31, 2022 | -15.44 Mn |
| Sep 30, 2022 | -6.63 Mn |
| Jun 30, 2022 | -6.34 Mn |
| Mar 31, 2022 | -7.10 Mn |
| Dec 31, 2021 | 46.62 Mn |
| Sep 30, 2021 | -22.68 Mn |
API Access
ARS Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();